Group 1 - The company held meetings on August 27, 2025, to review and approve the profit distribution plan for the first half of 2025, which will be submitted to the third extraordinary general meeting of shareholders for approval [1][2] - The proposed profit distribution plan includes a cash dividend of 1 yuan (including tax) for every 10 shares, with no stock dividends or capital reserve transfers [2][3] - The company's net profit for the first half of 2025 was -6,744,251.38 yuan, and the actual distributable profit as of June 30, 2025, was 96,821,547.99 yuan [2][3] Group 2 - The independent directors believe the profit distribution plan considers the company's operational status, future development, and reasonable shareholder returns, aligning with the company's articles of association and legal regulations [1][2] - The supervisory board agrees that the profit distribution plan takes into account the company's profitability and funding needs, ensuring it does not harm the overall interests of the company and its shareholders [2][3] - The cash dividend plan is deemed reasonable and aligns with the company's growth and operational scale, ensuring that it will not adversely affect the company's liquidity or long-term development [4]
泰林生物: 2025年半年度利润分配方案